We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-17.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
-$1.36B
(-19%)
Cap. Flow
-$72.7M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
17.58%
Holding
1,139
New
165
Increased
376
Reduced
380
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$58.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$27.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$23.3M |
| 4 |
TJX Companies
TJX
|
+$23.1M |
| 5 |
Synopsys
SNPS
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$45.2M |
| 2 |
Rockwell Automation
ROK
|
+$25.3M |
| 3 |
Accenture
ACN
|
+$24M |
| 4 |
Visteon
VC
|
+$23.4M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.85% |
| 2 | Financials | 17.71% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRC
876
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $205K | ﹤0.01% |
2,310
-3,920
| -63% | -$356K |
|
|
RYZ
877
Ryerson Holding Corp
RYZ
$1.6B
| $204K | ﹤0.01% |
32,239
+1,377
| +4% | +$11.9K |
|
878
Unitil
UTL
$1,000M
| $203K | ﹤0.01% |
4,018
-5,803
| -59% | -$289K |
|
879
IES Holdings
IESC
$12.5B
| $200K | ﹤0.01% |
+12,889
| New | +$223K |
|
|
TSC
880
DELISTED
TriState Capital Holdings, Inc.
TSC
| $200K | ﹤0.01% |
10,267
-12,172
| -54% | -$295K |
|
881
RBB Bancorp
RBB
$446M
| $199K | ﹤0.01% |
11,317
-18,698
| -62% | -$401K |
|
|
PMBC
882
DELISTED
Pacific Mercantile Bancorp
PMBC
| $199K | ﹤0.01% |
27,788
+8,418
| +43% | +$67.5K |
|
883
Foster
FSTR
$443M
| $198K | ﹤0.01% |
12,451
+2,500
| +25% | +$46.7K |
|
884
Donegal Group Class A
DGICA
$695M
| $197K | ﹤0.01% |
+14,463
| New | +$200K |
|
885
Spok Holdings
SPOK
$221M
| $197K | ﹤0.01% |
14,884
| – | – |
|
|
AMBR
886
DELISTED
Amber Road Inc
AMBR
| $197K | ﹤0.01% |
23,900
-1,500
| -6% | -$13.3K |
|
|
TTSH
887
DELISTED
Tile Shop Holdings
TTSH
| $196K | ﹤0.01% |
+35,676
| New | +$218K |
|
|
RARX
888
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $195K | ﹤0.01% |
+10,736
| New | +$169K |
|
889
Donnelley Financial Solutions
DFIN
$1.21B
| $194K | ﹤0.01% |
+13,810
| New | +$221K |
|
890
Builders FirstSource
BLDR
$7.84B
| $191K | ﹤0.01% |
17,500
-115,374
| -87% | -$1.45M |
|
891
Ovid Therapeutics
OVID
$435M
| $191K | ﹤0.01% |
79,094
+44,984
| +132% | +$205K |
|
892
Protagonist Therapeutics
PTGX
$8.75B
| $191K | ﹤0.01% |
28,400
+1,900
| +7% | +$15.1K |
|
893
Syndax Pharmaceuticals
SNDX
$1.84B
| $191K | ﹤0.01% |
42,939
-20,976
| -33% | -$115K |
|
894
Destination XL Group
DXLG
$34.7M
| $190K | ﹤0.01% |
+87,330
| New | +$234K |
|
895
Aviat Networks
AVNW
$262M
| $188K | ﹤0.01% |
28,392
+5,000
| +21% | +$37.2K |
|
|
HMHC
896
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $188K | ﹤0.01% |
+21,266
| New | +$168K |
|
|
DRRX
897
DELISTED
DURECT Corp
DRRX
| $185K | ﹤0.01% |
38,297
-867
| -2% | -$7.57K |
|
898
Vaalco Energy
EGY
$594M
| $185K | ﹤0.01% |
125,950
-65,769
| -34% | -$126K |
|
899
Crawford & Co Class B
CRD.B
$493M
| $183K | ﹤0.01% |
+20,290
| New | +$184K |
|
900
Ardelyx
ARDX
$1.24B
| $178K | ﹤0.01% |
99,614
+15,400
| +18% | +$45.3K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2018 Portfolio in Review
As of Q4 2018, Jacobs Levy Equity Management held 1,139 positions worth $5.69B, down 19% from $7.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2018 filing shows 165 new, 376 increased, 380 reduced and 175 closed positions. Its largest new stake was Starbucks: 930,980 shares worth $60M. The largest sale was Dell, an estimated $45.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2018 buy was Starbucks: 930,980 shares worth $60M.
- Jacobs Levy Equity Management added most to Celgene Corp in Q4 2018, an estimated $27.6M increase.
- Jacobs Levy Equity Management's biggest Q4 2018 reduction was Accenture, cutting an estimated $24M.
- Jacobs Levy Equity Management fully exited Dell in Q4 2018, selling an estimated $45.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $5.69B portfolio in Q4 2018.
- Jacobs Levy Equity Management opened 165 new positions and closed 175 in Q4 2018.
- Jacobs Levy Equity Management's portfolio value fell 19% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2018, filed 14 Feb 2019.